TV Show: Management of Acute Exacerbations of COPD
The majority of patients who present with an exacerbation of COPD, will inevitably end up on antibiotics. The PACE study found that CRP accurately guides antibiotic prescribing, and more importantly, signposts which patients do not need antibiotics.
The All-Wales Acute Exacerbation of COPD Pathway is the first national guideline to include C-Reactive Protein (CRP) point of care testing to guide antibiotic prescribing. The aim of this guideline is to reduce overall antibiotic prescribing for patients presenting to primary care with a COPD exacerbation.
In this episode, we are joined by Dr Simon Barry, National Respiratory Clinical Lead and Consultant Respiratory Physician, to unveil The All Wales Management of Acute COPD Exacerbation Guideline.
TV Show: Management of Acute Exacerbations of COPD
The majority of patients who present with an exacerbation of COPD, will inevitably end up on antibiotics. The PACE study found that CRP accurately guides antibiotic prescribing, and more importantly, signposts which patients do not need antibiotics.
The All-Wales Acute Exacerbation of COPD Pathway is the first national guideline to include C-Reactive Protein (CRP) point of care testing to guide antibiotic prescribing. The aim of this guideline is to reduce overall antibiotic prescribing for patients presenting to primary care with a COPD exacerbation.
In this episode, we are joined by Dr Simon Barry, National Respiratory Clinical Lead and Consultant Respiratory Physician, to unveil The All Wales Management of Acute COPD Exacerbation Guideline.
Resources
 |
|---|
The All Wales Primary Care Management of Acute COPD Exacerbation Guideline
The All-Wales Acute Exacerbation of COPD Pathway is the first national guideline to include C-Reactive Protein (CRP) point of care testing to guide antibiotic prescribing. The aim of this guideline is to reduce overall antibiotic prescribing for patients presenting to primary care with a COPD exacerbation.
